CardiacSense

Caesarea, Israel Founded: 2012 • Age: 14 yrs Minicorn
Provider of sensor to monitor heart arrhythmia and vital signs

About CardiacSense

CardiacSense is a Healthcare company based in Caesarea (Israel) founded in 2012. Provider of sensor to monitor heart arrhythmia and vital signs. It operates in the Healthcare and Technology sectors. CardiacSense has raised $10 million across 5 funding rounds from investors including European Union and EIC Fund. CardiacSense was last valued at $20.5 million in May 2018. Its focus areas include HealthTech, Disease Self Management, Body Health Parameters and Monitoring.

Company details

CardiacSense was founded in 2012 in Caesarea, Israel, within the medical technology sector. Non-invasive wrist-worn sensors are developed by the company to enable continuous monitoring and diagnosis of cardiac conditions, including arrhythmia, cardiac arrest, and atrial fibrillation, along with vital signs. Operations focus on healthcare applications for patient surveillance in clinical and remote settings.

Key Metrics
  • Total Equity Funding
    $10M (USD)

    in 5 rounds

  • Latest Funding Round
    $6M (USD), Series B

    Jun 2020

  • Investors

Apps and channels of CardiacSense

its YouTube channel CardiacSense has 255 subscribers and 24 videos.

CardiacSense
YouTube 255 subscribers 24 videos Science & Technology
Open channel

Videos from CardiacSense

The most watched videos on CardiacSense's YouTube channel, CardiacSense (255 subscribers). Click a video to play it here.

What is COPD and why it's crucial to monitor oxygen levels and respiratory rate? Rob Swanda explains
12K views
CardiacSense Medical Watch - Record an ECG and perform Real-Time Measurements
5.9K views
Meet the CardiacSense Medical Watch
4K views
What is Oxygen Saturation SpO2 and why you must know its level? Rob Swanda explains
3.5K views

More on CardiacSense.

Funding Insights of CardiacSense

CardiacSense has successfully raised a total of $10M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $6 million completed in June 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $10M
  • Total Rounds 5
  • Last Round Series B β€” $6M
  • First Round $500,000

    (May 2018)

  • Investors Count 2

All 5 funding rounds of CardiacSense with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2020$6MSeries B––
–
May 2019$3.5MSeries A––
–
Mar 2019$56,080Grant––
Dec 2018$56,595Grant––
May 2018$500,000Seed$20.5M–
–
Valuation history
DateValuationStage
May 2018$20.5Mβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $20.5M (May 2018). 2 investors in total: 2 institutional.

Investors in CardiacSense

CardiacSense has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include European Union and EIC Fund.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Government agency and accelerator focusing on innovative startups and SMEs
eicfund.euBrussels, Belgium
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for CardiacSense

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of CardiacSense

3 people are tracked at CardiacSense (1 in leadership, 2 in team).

NameRoleGroup
Amnon Blanca
Vice President Of Business DevelopmentLeadership
Nick Byrne
Business Consultant - UKTeam
Neeraj Sirari
Regional Business ManagerTeam
Premium access

Complete people profiles for CardiacSense

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of CardiacSense

4 dated milestones of CardiacSense across 8 years, from founding to its latest funding, stage changes and deals.

  1. Founded CardiacSense is founded.
  2. Funding First funding round of $500K.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Series B, of $6.0M.

Web traffic of CardiacSense

The website of CardiacSense (cardiacsense.com) receives about 9.4K visits a month.

  • Monthly visits
    9.4K

    ▼ 19.2% vs previous month

Similar websites

Websites whose visitors overlap most with CardiacSense. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
cardionics.com
100%
4.2K#4,707,252View details
terumomedical.com
95%
14.7K#1,709,290View details
mcra.com
95%
17K#1,475,794View details
hilo.com
80%
313.8K#157,740View details
medicalfuturist.com
80%
#363,346View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 8 similar websites and full traffic analytics for CardiacSense

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 8 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Cardiacsense

Premium access

Complete news archive for CardiacSense

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about CardiacSense

CardiacSense was founded in 2012 and raised its 1st funding round 6 years after it was founded.

CardiacSense is headquartered in Caesarea, Israel. It is registered at Caesarea, Haifa, Israel.

CardiacSense is a funded company, having raised a total of $10M across 5 funding rounds to date. The company's 1st funding round was a Seed of $500K, raised on May 2018.

CardiacSense was founded in 2012 in Caesarea, Israel, within the medical technology sector. Non-invasive wrist-worn sensors are developed by the company to enable continuous monitoring and diagnosis of cardiac conditions, including arrhythmia, cardiac arrest, and atrial fibrillation, along with vital signs. Operations focus on healthcare applications for patient surveillance in clinical and remote settings.

CardiacSense has 2 investors. Key investors include European Union, and EIC Fund.

The valuation of CardiacSense is $20.5M as of May 2018.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available